Skip to main content

Biomarin Pharmaceutical Inc

BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001048477

In the last 90 days, Biomarin Pharmaceutical Inc insiders filed 0 open-market purchases and 1 sale; 565 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q3 2022

Institutional positions in Biomarin Pharmaceutical Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
552
+12 vs. Q2 2022
Shares held
182.2M
+3.21M (+1.8%) vs. Q2 2022
Total value
$15.5B
+$606.0M (+4.1%) vs. Q2 2022
New holders
62
215 more added
Sold out
50
178 more reduced

4 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BMRN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 552 institutions
Q1 2021: 532 institutionsQ2 2021: 531 institutionsQ3 2021: 514 institutionsQ4 2021: 557 institutionsQ1 2022: 560 institutionsQ2 2022: 544 institutionsQ3 2022: 552 institutionsQ4 2022: 581 institutionsQ1 2023: 554 institutionsQ2 2023: 559 institutionsQ3 2023: 521 institutionsQ4 2023: 549 institutionsQ1 2024: 560 institutionsQ2 2024: 561 institutionsQ3 2024: 556 institutionsQ4 2024: 544 institutionsQ1 2025: 584 institutionsQ2 2025: 582 institutionsQ3 2025: 577 institutionsQ4 2025: 539 institutionsQ1 2026: 559 institutionsQ2 2026: 565 institutions
Value heldQ3 2022: $15.5B
Q1 2021: $13.5BQ2 2021: $14.7BQ3 2021: $13.6BQ4 2021: $15.7BQ1 2022: $13.7BQ2 2022: $14.8BQ3 2022: $15.5BQ4 2022: $18.9BQ1 2023: $17.4BQ2 2023: $15.5BQ3 2023: $16.1BQ4 2023: $17.9BQ1 2024: $16.3BQ2 2024: $15.2BQ3 2024: $12.7BQ4 2024: $12.0BQ1 2025: $13.0BQ2 2025: $10.1BQ3 2025: $9.72BQ4 2025: $11.2BQ1 2026: $10.4BQ2 2026: $11.1B
Institutions holding BMRN and their total value by quarter
QuarterHoldersValue
Q2 2026565$11.1B
Q1 2026559$10.4B
Q4 2025539$11.2B
Q3 2025577$9.72B
Q2 2025582$10.1B
Q1 2025584$13.0B
Q4 2024544$12.0B
Q3 2024556$12.7B
Q2 2024561$15.2B
Q1 2024560$16.3B
Q4 2023549$17.9B
Q3 2023521$16.1B
Q2 2023559$15.5B
Q1 2023554$17.4B
Q4 2022581$18.9B
Q3 2022552$15.5B
Q2 2022544$14.8B
Q1 2022560$13.7B
Q4 2021557$15.7B
Q3 2021514$13.6B
Q2 2021531$14.7B
Q1 2021532$13.5B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Biomarin Pharmaceutical Inc; share changes are against Q2 2022.

Institutions holding BMRN in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Steward Financial Group LLC0$00.00%−18−100.0%Sold out
Psagot Value Holdings Ltd. / (Israel)0$00.00%−12−100.0%Sold out
Exane Derivatives––––Not filed
Fieldpoint Private Securities, LLC––––Not filed
Brewin Dolphin Ltd––––Not filed
Lake Point Wealth Management––––Not filed